$4.31 Billion Worldwide Hematology Analyzers and Reagents Industry to 2030 - Identify Growth Segments for Investment
December 30, 2021 05:33 ET
|
Research and Markets
Dublin, Dec. 30, 2021 (GLOBE NEWSWIRE) -- The "Hematology Analyzers and Reagents Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's...
Imara to Present Clinical and Preclinical Data at the American Society of Hematology (ASH) Annual Meeting 2021
November 04, 2021 09:17 ET
|
Imara, Inc.
Tovinontrine (IMR-687) VOC data in patients with sickle cell disease from ongoing Phase 2a open-label extension study and preclinical models of beta-thalassemia to be presented Oral presentation...
Global Diabetes Diagnostics Market Report 2021: Market to Reach $42.4 Billion by 2026 - U.S. Market is Estimated at $10.8 Billion, While China is Forecast to Reach $5.2 Billion
July 20, 2021 04:33 ET
|
Research and Markets
Dublin, July 20, 2021 (GLOBE NEWSWIRE) -- The "Diabetes Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Diabetes...
Imara Announces Recipients of the Second Annual Real Impact Grants Program to Support People Affected by Rare Genetic Blood Disorders
June 17, 2021 07:00 ET
|
Imara, Inc.
BOSTON, June 17, 2021 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients...
Imara Presents Clinical Data on IMR-687 in Sickle Cell Disease at the European Hematology Association (EHA) Annual Congress
June 11, 2021 03:00 ET
|
Imara, Inc.
Final data from 93-patient Phase 2a clinical trial show lower annualized rate of vaso-occlusive crises (VOCs) and longer time to first VOC on IMR-687 Interim open-label extension clinical trial...
Global Sickle Cell Anemia Market Report 2021-2031: Key Marketed and Pipeline Drugs, Clinical Trials, Recent Events, Regulatory Events, Success Probability, Disease Prevalence, Licensing & Acquisition
June 09, 2021 08:53 ET
|
Research and Markets
Dublin, June 09, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Sickle Cell Anemia" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the Sickle Cell...
Worldwide Hemoglobin Testing Industry to 2026 - Players Include Abbott, Bio-Rad Laboratories and Danaher Among Others
May 14, 2021 06:53 ET
|
Research and Markets
Dublin, May 14, 2021 (GLOBE NEWSWIRE) -- The "Hemoglobin Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
Imara to Webcast Conference Call of First Quarter 2021 Financial Results and Business Highlights
May 04, 2021 07:00 ET
|
Imara, Inc.
BOSTON, May 04, 2021 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients...
Global Hemoglobin A1C Monitoring Market Report 2021-2027 - U.S. Market is Estimated at $275.9 Million, While China is Forecast to Grow at 11.8% CAGR
April 23, 2021 05:33 ET
|
Research and Markets
Dublin, April 23, 2021 (GLOBE NEWSWIRE) -- The "Hemoglobin A1C Monitoring - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Hemoglobin...
Global Blood Therapeutics Announces Participation at Three September Conferences
September 03, 2015 07:35 ET
|
Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT), a biopharmaceutical company developing novel therapeutics for the treatment of...